Ofatumumab is first self-administered, targeted B-cell treatment for relapsing MS. The first self-administered, targeted B-cell treatment for relapsing multiple sclerosis (多发性硬化症) received FDA approval
干细胞疗法
肝脏干细胞疗法
失代偿期肝硬化患者大多不得不选择肝移植, 但捐献器官的供应有限且成本高昂导致等待名单上的死亡率很高 . 自己身体的干细胞有帮助 阅读更多…
